| Diversicare Of Oxford | |
| 1130 South Hale Street, Oxford, Alabama 36203 | |
| (256) 831-0481 | |
| Name | Diversicare Of Oxford |
|---|---|
| Location | 1130 South Hale Street, Oxford, Alabama |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 173 |
| Occupancy Rate | 67.4% |
| Medicare ID (CCN) | 015132 |
| Legal Business Name | Diversicare Of Oxford Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1306391495 |
| Organization Name | DIVERSICARE OF OXFORD, LLC |
| Doing Business As | DIVERSICARE OF OXFORD |
| Address | 1130 Hale St, Oxford, AL 36203 |
| Phone Number | 256-831-0481 |
News Archive
Eli Lilly and Company today announced that a total of 14 U.S. and global studies involving its osteoporosis medications, FORTEO® [teriparatide (rDNA origin) injection] and EVISTA® (raloxifene HCl tablets), will be presented at the American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting from October 15-19 in Toronto, ON, Canada.
Scientists at A*STAR's Singapore Immunology Network (SIgN) uncovered the origin of a group of skin-deep immune cells that act as the first line of defence against harmful germs and skin infections. SIgN scientists discovered that these sentry cells of the skin, called the Langerhans cells (LCs), originate from two distinct embryonic sites - the early yolk sac and the foetal liver.
Much has been published of late, in medical journals as well as in the general media, concerning the national rise in both the Cesarean section and premature birth rates. While not directly connected, the two medical concerns have many interrelated variables. Nationally, the Cesarean section rate has risen to 32 percent of all births, while the rate of premature birth has climbed to just over 12 percent.
Velocity Technology Solutions, Inc. a leader in cloud-based enterprise software hosting, application management, and consulting services, announced today that it was selected by the St. Charles Health System, Inc. to host and fully-manage its Lawson enterprise resource planning applications and Kronos time and labor management applications. Velocity's expertise and demonstrated leadership in supporting the Lawson and Kronos applications, as well as its partnership with both software providers, were driving forces behind St. Charles' decision.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Eli Lilly and Company today announced that a total of 14 U.S. and global studies involving its osteoporosis medications, FORTEO® [teriparatide (rDNA origin) injection] and EVISTA® (raloxifene HCl tablets), will be presented at the American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting from October 15-19 in Toronto, ON, Canada.
Scientists at A*STAR's Singapore Immunology Network (SIgN) uncovered the origin of a group of skin-deep immune cells that act as the first line of defence against harmful germs and skin infections. SIgN scientists discovered that these sentry cells of the skin, called the Langerhans cells (LCs), originate from two distinct embryonic sites - the early yolk sac and the foetal liver.
Much has been published of late, in medical journals as well as in the general media, concerning the national rise in both the Cesarean section and premature birth rates. While not directly connected, the two medical concerns have many interrelated variables. Nationally, the Cesarean section rate has risen to 32 percent of all births, while the rate of premature birth has climbed to just over 12 percent.
Velocity Technology Solutions, Inc. a leader in cloud-based enterprise software hosting, application management, and consulting services, announced today that it was selected by the St. Charles Health System, Inc. to host and fully-manage its Lawson enterprise resource planning applications and Kronos time and labor management applications. Velocity's expertise and demonstrated leadership in supporting the Lawson and Kronos applications, as well as its partnership with both software providers, were driving forces behind St. Charles' decision.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 13.62 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.34 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 29.8 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.64 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.01 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.23 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 15.34 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.27 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.65 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 12.15 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 21.96 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 5.49 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 89.15 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 93.13 | 82.93 |
News Archive
Eli Lilly and Company today announced that a total of 14 U.S. and global studies involving its osteoporosis medications, FORTEO® [teriparatide (rDNA origin) injection] and EVISTA® (raloxifene HCl tablets), will be presented at the American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting from October 15-19 in Toronto, ON, Canada.
Scientists at A*STAR's Singapore Immunology Network (SIgN) uncovered the origin of a group of skin-deep immune cells that act as the first line of defence against harmful germs and skin infections. SIgN scientists discovered that these sentry cells of the skin, called the Langerhans cells (LCs), originate from two distinct embryonic sites - the early yolk sac and the foetal liver.
Much has been published of late, in medical journals as well as in the general media, concerning the national rise in both the Cesarean section and premature birth rates. While not directly connected, the two medical concerns have many interrelated variables. Nationally, the Cesarean section rate has risen to 32 percent of all births, while the rate of premature birth has climbed to just over 12 percent.
Velocity Technology Solutions, Inc. a leader in cloud-based enterprise software hosting, application management, and consulting services, announced today that it was selected by the St. Charles Health System, Inc. to host and fully-manage its Lawson enterprise resource planning applications and Kronos time and labor management applications. Velocity's expertise and demonstrated leadership in supporting the Lawson and Kronos applications, as well as its partnership with both software providers, were driving forces behind St. Charles' decision.
› Verified 3 days ago